XPMag - Explant Transfection -siRNA Transfection Reagent

New Transfection Kit
XPMagis a novel magnetic nanoparticles formulation dedicated to gene transfection in organotypic cultures of explant by “Reverse Magnetofection”.
“Reverse Magnetofection” provides a novel and non-toxic strategy for nucleic acids (DNA & siRNA) based gene therapy in the retina that can be translated to a wide variety of organ explants.
XPMagassociated with Reverse Magnetofection allows the delivery of nucleic acids (NA) up to the deepest explant layers.
The magnetic force, delivered by a specific magnetic plate, guides and concentrates complexes of NA and XPMag magnetic nanoparticles from the culture media to the tissue. This novel method of transfection associating XPMag and Reverse Magnetofection is fully biocompatible and does induce neither apoptosis nor inflammatory reactions.
XPMag transfection reagent

MAIN BENEFITS:
Highly efficient with microglial cell lines & primary cells
Low nucleic acid amount - minimized toxicity
High level of nucleic acid compaction
Easy and straightforward protocol
Compatible with any culture medium.

Sizes :
XP00250: 250 µL of XPMag reagent
XP00500: 500 µL of XPMag reagent
KXP0250: XPMag Starting Kit - 250 µL of XPMAg reagent + Super Magnetic Plate
Supplier Amerigo Scientific
Product # XP00250
Pricing 250 µL; 500 µL; Starting Kit, Inquire
Feedback